4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidine

Catalog No.: 
ACTKJA837
CAS No.: 
87412-89-3
Molecular Formula: 
C7H7ClN4
Molecular Weight: 
182.61
4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$367.00InquiryInquiry
250mg95%$858.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name4-chloro-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidine
MDL No.MFCD09901801
Molecular FormulaC7H7ClN4
Molecular Weight182.61
SMILESCC1=NN(C)C2=NC=NC(Cl)=C21
InChI KeyRKCUSLQIKDPCGC-UHFFFAOYSA-N
Synonym4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidine;4-chloro-1,3-dimethylpyrazolo<3,4-d>pyrimidine;1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1,3-dimethyl-
CAS No.87412-89-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTKJA837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOEDV257 route compound structure diagram
    ACOEDV257871335-85-2In Stock
  4. Then
  5. ACTKJA837 route product structure diagram
    ACTKJA83787412-89-3
Inquiry

2. ACTKJA837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBUQC472 route compound structure diagram
    ACBUQC47260025-06-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKJA837 route product structure diagram
    ACTKJA83787412-89-3
Inquiry

3. ACTKJA837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKJA837 route product structure diagram
    ACTKJA83787412-89-3
Inquiry

Comments (0)